Caution before canonisation: a clinical and implementation science perspective on psychedelics
Recent advances in psychedelic research have renewed interest in the potential therapeutic role of psychedelic-assisted interventions in psychiatry. Early clinical trials suggest that compounds such as psilocybin and MDMA, administered within structured therapeutic frameworks, may produce rapid symptom improvements for conditions including depression, post-traumatic stress disorder, and substance…
Read original article on Frontiers in Psychiatry | New and Recent Articles →Related news
-
18 Habits that Often Make Our Lives 98 Percent Harder
United States
-
Editorial: Sensory processing in autism: mechanisms, impacts and interventions
Switzerland
-
Understanding non-psychiatric nurses’ experiences of caring for patients with mental-physical comorbidity: a descriptive phenomenological study
Switzerland
-
Incidence and risk factors for enteral nutrition intolerance in psychiatric patients with comorbid medical conditions: a retrospective cohort study
Switzerland
-
Reduced contagious yawning in psychiatric disorders: a systematic review of potential social-cognitive mechanisms
Switzerland
-
Benzodiazepine prescribing in chronic military-related PTSD: real-world patterns and correlates in specialized care
Switzerland
-
The Song of the Earth
United States
-
Buddhist Bubblegum
United States